Skip to main content

Table 1 Maternal baseline characteristics of the study groups

From: Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus

 

Control group (n = 60)

isCGM group (n = 64)

p-value

Maternal age (years)

30.6 ± 3.1

31.2 ± 4.1

0.604

Gestational age at first visit (w)

9.4 ± 2.9

9.5 ± 2.5

0.726

Family history of DM, n (%)

21 (35.0)

23 (35.9)

0.732

Duration of diabetes (years)

5.2 ± 1.4

4.9 ± 1.2

0.728

University and above, n (%)

34 (56.7)

36 (56.2)

0.823

Severe hypoglycaemia in past year, n (%)

2 (3.3)

3 (4.7)

0.793

Total insulin dose (U/kg per day)

0.69 ± 0.14

0.65 ± 0.13

0.743

Chronic hypertension, n (%)

2 (3.3)

2 (3.1)

0.875

Abortion history, n (%)

11 (18.3)

12 (18.7)

0.842

Nulliparity, n (%)

35 (58.3)

39 (60.9)

0.732

ART, n (%)

2 (3.3)

3 (4.7)

0.531

History of macrosomia childbirth, n(%)

6 (10.0)

8 (12.5)

0.689

Pre-pregnancy BMI (kg/m2)

25.6 ± 2.9

25.7 ± 3.3

0.878

Overweight (%) at first visit 25 ≤ BMI < 28

35(58.3)

37(57.8)

0.741

Obesity(%) at first visit BMI ≥ 28

14 (23.3)

16 (25.0)

0.625

  1. Severe hypoglycaemia was defined as an episode requiring third-party assistance
  2. ART assisted reproductive technology, BMI (kg/m2) body mass index